November 30th, 2007 amy
Johnson & Johnson faces lawsuits of nearly 2,500 women who claim the company withheld and altered data that its Ortho Evra birth control patch could cause strokes, heart attacks, and blood clots in the legs and lungs at a higher risk than oral contraceptives.
These lawsuits are uncovering evidence that the company knew of the risks […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Posted in Uncategorized by: amy
No Comments
November 29th, 2007 amy
Sanofi-Aventis is facing another Ketek lawsuit, this one with 47 plaintiffs. Ketek was approved in 2004 for treating chronic bronchitis, pneumonia and sinus infections. The drug has since been linked to liver damage sever enough to require a transplant or cause death in some cases. Sanofi-Aventis, makers of the drug, faces multiple lawsuits. This one […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Posted in Uncategorized by: amy
No Comments
November 28th, 2007 amy
Yesterday, Novartis and FDA informed healthcare professionals and patients that use of Myfortic Delayed- Release Tablets during pregnancy is associated with increased risks of pregnancy loss and congenital malformations. The pregnancy category for Myfortic has been changed to Category D (Positive evidence of fetal risk). This change is a result of postmarketing data from the […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Posted in Uncategorized by: amy
No Comments
November 27th, 2007 amy
Tamiflu is being investigated by the Food & Drug Administration (FDA) after researchers found that 25 young people in Japan died while taking the drug. Reports suggest that side effects to this flu medication may cause hallucinations and delirium, as well as convulsions.
Tamiflu’s warning label already warns those taking the drug to watch “for abnormal […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Posted in Uncategorized by: amy
No Comments
November 26th, 2007 amy
GlaxoSmithKline PLC asthma drugs Serevent and Advair have fallen under scrutiny of the FDA once again, this time to determine whether these drugs may be dangerous to children after a safety review uncovered the deaths of five children taking Serevent.
“Nine patients under age 16 were harmed, including five who died, while taking Serevent in the […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Posted in Uncategorized by: amy
No Comments
November 23rd, 2007 amy
On November 21, lawyersandsettlements.com article “Zyprexa Side Effects are Deadly” paints a grim but dead on picture of the realities of popular schizophrenia drug Zyprexa: “Seniors with dementia who are given the drug are at an increased risk of death, adults and children have a risk of suicidal tendencies and those who survive that may […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Posted in Uncategorized by: amy
No Comments
November 21st, 2007 amy
Merck has agreed to pay a settlement of $4.85 billion to end litigation over injury claims associated with its pain reliever Vioxx, which has been linked to heart attack and stroke. Vioxx was taken off the market in 2004. Merck was left facing 27,000 lawsuits comprised of tens of thousands of injury claims. The $4.85 […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Posted in Uncategorized by: amy
No Comments
November 20th, 2007 amy
According to a report by the U.S. Senate Finance Committee, GlaxoSmithKline PLC went to great lengths to stifle the concerns of a physician about the company’s diabetes drug Avandia, which has been connected to six cases of congestive heart failure in patients taking the drug.
Per the report, Dr. John Buse, a diabetes expert and professor […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Posted in Uncategorized by: amy
No Comments
November 19th, 2007 amy
Sanofi-Aventis’ anti-obesity drug Acomplia has researchers concerned that the more than doubled risk for depression, anxiety and suicidal thoughts may cause more harm than good.
A group of Danish researchers reviewed four studies conducted on 4,105 patients and found that patients were 2.5 times more likely to quit treatment from experiencing depressive disorders and 3 times […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Posted in Uncategorized by: amy
No Comments
November 16th, 2007 amy
On November 12, Cephalon announced its agreement to pay $425 million to the U.S. Justice Department to resolve claims alleging the company promoted its painkillers Fentora and Actiq for off-label use, encouraging doctors to prescribe medications for treatment of conditions the FDA hasn’t approved the drug to be used for. While doctors are allowed […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Posted in Uncategorized by: amy
No Comments